Publicaciones (154) Publicaciones en las que ha participado algún/a investigador/a

2013

  1. 2013 ESC guidelines on the management of stable coronary artery disease

    European Heart Journal, Vol. 34, Núm. 38, pp. 2949-3003

  2. A 58-year old male referred for consultation due to pathological ECG finding

    Medicine (Spain), Vol. 11, Núm. 42

  3. A comparison of the CKD-EPI, MDRD-4, and Cockcroft-Gault equations to assess renal function in predicting all-cause mortality in acute coronary syndrome patients

    International Journal of Cardiology, Vol. 167, Núm. 5, pp. 2325-2326

  4. A novel electrocardiographic index for the diagnosis of diastolic dysfunction

    PLoS ONE, Vol. 8, Núm. 11

  5. Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): A randomised, controlled, non-inferiority trial

    The Lancet, Vol. 381, Núm. 9867, pp. 651-660

  6. Acceso radial frente a femoral después de una intervención coronaria percutánea en infarto agudo de miocardio con elevación del segmento ST. Resultados de mortalidad a 30 días y a 1 año

    Revista Espanola de Cardiologia, Vol. 66, Núm. 11, pp. 871-878

  7. Actualización en cardiopatía isquémica y cuidados críticos cardiológicos

    Revista Espanola de Cardiologia, Vol. 66, Núm. 3, pp. 198-204

  8. Adiponectin and resistin serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy

    Clinical and Experimental Rheumatology, Vol. 31, Núm. 3, pp. 365-371

  9. Alteraciones electrocardiográficas en un breve espacio de tiempo

    Cadernos de atención primaria, Vol. 19, Núm. 3, pp. 202-208

  10. Angiopoietin-2 serum levels correlate with severity, early onset and cardiovascular disease in patients with rheumatoid arthritis

    Clinical and Experimental Rheumatology, Vol. 31, Núm. 5, pp. 761-766

  11. Apelin serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy

    Clinical and Experimental Rheumatology, Vol. 31, Núm. 4, pp. 532-537

  12. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry

    European Journal of Heart Failure, Vol. 15, Núm. 10, pp. 1173-1184

  13. Are some of the last advances in cardiovascular therapeutics fighting against the historic evolution of the heart and the cardiovascular system?

    International Journal of Cardiology, Vol. 168, Núm. 4, pp. 4276-4277

  14. Arritmias

    Medicine (Spain), Vol. 11, Núm. 38, pp. 2281-2287

  15. Arritmias

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 11, Núm. 38, pp. 2281-2287

  16. Asymmetric dimethylarginine serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy

    Clinical and Experimental Rheumatology, Vol. 31, Núm. 5, pp. 749-755

  17. Atrial fibrillation outcomes: Changing the paradigm

    International Journal of Cardiology, Vol. 166, Núm. 2, pp. 545-547

  18. Availability and characteristics of cardiovascular rehabilitation programs in South America

    Journal of Cardiopulmonary Rehabilitation and Prevention, Vol. 33, Núm. 1, pp. 33-41

  19. Benefits of delapril in hypertensive patients along the cardiovascular continuum

    Expert Review of Cardiovascular Therapy, Vol. 11, Núm. 3, pp. 271-281

  20. Bochdalek hernia causing pulmonary hypertension

    Circulation, Vol. 127, Núm. 17, pp. 1837-1839